unknown
Stage
2
Investors
About
evitria AG is a contract research organization (CRO) specializing in the transient expression and production of recombinant antibodies and proteins. They provide services from gene synthesis to protein purification for biotech and pharmaceutical companies.
Explore evitria AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.